Sobi

Highly Engaged Employees

Sobi is an international biopharmaceutical company headquartered in Stockholm, Sweden, established in 2011. The firm specializes in the development and commercialization of innovative therapies, with a primary research focus on hematology and immunology. By leveraging advanced biotechnology, Sobi addresses significant unmet medical needs for patients suffering from rare diseases. The company maintains a robust pipeline of specialty healthcare products, positioning itself as a leader in value-driven treatment solutions within the global pharmaceutical landscape.

Operating with a workforce of 1,000-5,000 employees, Sobi manages its global operations across 3 strategic locations. The organization integrates in-house research and development with commercial expertise to deliver high-impact patient outcomes. Meet Sobi's team to understand the leadership and scientific expertise driving their operational success. The company’s commitment to scientific excellence is reflected in its diverse portfolio of specialty healthcare treatments, which are designed to improve the quality of life for patients worldwide through innovative half-life extension technologies and targeted therapeutic interventions.

Financially, Sobi demonstrates strong market performance, reporting annual revenue of approximately $3.0B. The company’s growth strategy is supported by strategic funding initiatives, including debt financing and stock issuance, which bolster its capacity for continued innovation. Explore financial highlights to review detailed metrics regarding their fiscal performance and capital structure. As a publicly traded entity on the Stockholm Stock Exchange, Sobi continues to expand its footprint in the biopharmaceutical sector, maintaining a competitive edge through its specialized focus on rare disease management and patient-centric healthcare delivery models.